ArticleCureus2025
Pancreatic Schwannoma: A Rare Culprit But Accurate Diagnosis Can Avoid Resection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic schwannomas are extremely rare benign tumors originating from Schwann cells of peripheral nerves, often mimicking more common pancreatic tumors, such as neuroendocrine neoplasms or solid pseudopapillary neoplasms, making preoperative diagnosis challenging. We describe a 65-year-old asymptomatic man referred for evaluation of an incidental pancreatic body mass detected by ultrasound. Laboratory findings, including liver enzymes and tumor markers (CA19-9 and CEA), were normal. Contrast-enhanced CT revealed a well-defined 20 mm mass with delayed enhancement, and MRI showed low intensity on T1-weighted images, mildly high on T2, and slight diffusion restriction. Based on imaging, a pancreatic neuroendocrine neoplasm was initially suspected. Endoscopic ultrasound-guided tissue acquisition with a 22-gauge needle was performed. Histology revealed bundles of spindle-shaped cells with mild atypia and eosinophilic cytoplasm. Immunohistochemistry was diffusely positive for S-100 protein and negative for AE1/AE3, CD34, c-Kit, and desmin, confirming pancreatic schwannoma. Given its benign nature, the patient was managed conservatively without surgery, and no tumor growth was observed over two years of follow-up. This case highlights the importance of including schwannoma in the differential diagnosis of solid pancreatic lesions and illustrates how an endoscopic ultrasound (EUS)-guided biopsy with immunohistochemistry can enable accurate preoperative diagnosis and avoid unnecessary surgical resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.